Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
49.70    1.05 (2.16%)
Bid:
49.10
Ask:
49.70
Spread: 0.60 (1.222%)
Market Cap: £197.86m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Board Change

27 Nov 2008 15:30

CLS HOLDINGS PLC ("CLS" or "the Company") BOARD CHANGES

The Board of CLS Holdings plc is pleased to announce the appointment of Mr Joseph Crawley and Mr Chris Jarvis as Non-executive Directors with immediate effect.

In addition, Mr James Dean is to retire on 31st December 2008 as a Non-executive Director after over nine years of valuable service. James has also made an important contribution as a member of both the Audit Committee and of the Remuneration Committee, of which he was Chairman. Thomas Lundqvist and Joseph Crawley will be appointed as Chairman and Member of the Remuneration Committee respectively, Chris Jarvis will be appointed as a member of the Audit Committee and Malcolm Cooper will replace James as the Senior Independent Director. These committee changes are expected to take effect on 31st December 2008.

Joseph Crawley is Chief Executive of Kitewood Estates Ltd, a property investment and development company active in London and south-east England. Kitewood specialises in supplying residential property to housing associations and also has a commercial business which is developing a business park in Kent. Joe has considerable experience, knowledge and contacts relating to the central London property market and has been active in property development in the London area for over 20 years. He was previously employed by CLS from 1988 to 1991 when he was responsible for property development, including the development of the Spring Gardens site. He was CLS' Development Director from 1995 to September 1999.

Chris Jarvis FRICS is senior partner of Jarvis & Partners, a boutique real estate consultancy that he established in Berlin in 1994. Jarvis & Partners acquired a leading role in advising major tenants and owner occupiers in Germany with a client list including Linklaters, Clifford Chance and the European Central Bank. Jarvis & Partners' work has been involved in advising a number of German equity investors and working with German based international corporates on sale and leaseback deals in Europe. Prior to establishing Jarvis & Partners, Chris worked for Richard Ellis for 13 years in London and Germany, from 1988 to 1994 as Managing Director of Richard Ellis Germany.

Sten Mortstedt, Chairman, commented:

"We are delighted that Joe and Chris have agreed to join the Board. The Board thanks James for all he has done for CLS and wishes him well for the future."

Pursuant to Listing Rule 9.6.13 (3) Joseph Allen Crawley was an Executive Director of Groveclose Ltd which was voluntarily liquidated in 2001 and he resigned as a Director of Trinity Modular Technology Ltd on 1 October 1995 which was later put into liquidation in July 1996. No further information is required to be disclosed pursuant to LR 9.6.13 R. Joe does not have any beneficial interests in CLS ordinary shares.

No information is required to be disclosed pursuant to LR 9.6.13 R in respect of Christopher Patrick Jarvis and he does not have any beneficial interests in CLS ordinary shares.

Enquiries:

Sten Mortstedt, Executive Chairman, CLS Holdings plc +44 (0) 20 7582 7766

Henry Klotz, Chief Executive Officer, CLS Holdings plc +44 (0) 20 7582 7766

vendor
Date   Source Headline
20th Oct 20235:20 pmRNSDirector/PDMR Shareholding
25th Sep 20239:16 amPRNDirector Declaration
25th Sep 20237:00 amRNSDirectorate Change
12th Sep 20235:33 pmRNSDirector/PDMR Shareholding
12th Sep 20234:17 pmRNSDirector/PDMR Shareholding
4th Sep 20234:41 pmRNSDirector/PDMR Shareholding
4th Sep 20234:38 pmRNSTR-1 Notification of Major Holdings
23rd Aug 20234:05 pmRNSDirector/PDMR Shareholding
18th Aug 20233:59 pmRNSDirector/PDMR Shareholding
18th Aug 20233:55 pmRNSNotification of Major Shareholdings
11th Aug 20234:50 pmRNSDirector/PDMR Shareholding
1st Aug 202311:17 amRNSNotice of Results
7th Jul 20235:28 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:20 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCLS announces 30-year lease in Essen, Germany
27th Jun 20237:00 amRNSCLS announces the sale of three properties
23rd Jun 20233:15 pmRNSDirector/PDMR Shareholding
15th Jun 20235:51 pmRNSDirector/PDMR Shareholding
15th Jun 20235:49 pmRNSNotification of Major Shareholding
15th Jun 20235:44 pmRNSDirector/PDMR Shareholding
8th Jun 20232:14 pmRNSDirector/PDMR Shareholding
5th Jun 20234:51 pmRNSDirector/PDMR Shareholding
30th May 20232:55 pmRNSDirector/PDMR Shareholding
30th May 20232:52 pmRNSHolding(s) in Company
26th May 20234:39 pmRNSTotal Voting Rights
18th May 20237:02 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSHolding(s) in Company
12th May 20234:40 pmRNSDirector/PDMR Shareholding
11th May 20235:15 pmRNSDirector/PDMR Shareholding
27th Apr 20234:32 pmRNSResult of AGM
17th Apr 20231:57 pmRNSDirector/PDMR Shareholding
13th Apr 20233:51 pmRNSDirector/PDMR Shareholding
24th Mar 20237:22 amRNSNotice of Results
24th Mar 20237:17 amRNSDirector/PDMR Shareholding
15th Mar 20234:29 pmRNSDirector/PDMR Shareholding
15th Mar 20231:17 pmRNSDirector/PDMR Shareholding
10th Mar 20234:31 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSAnnual Financial Report
10th Feb 20235:02 pmRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSNotice of Full Year Results
17th Jan 20235:17 pmRNSDirector/PDMR Shareholding
20th Dec 20225:45 pmRNSDirector/PDMR Shareholding
29th Nov 202211:18 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSQ3 Trading Update
8th Nov 20227:00 amRNSCLS Secures Three New Leases in Germany
18th Oct 20223:14 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSDisposal
12th Oct 20223:28 pmRNSDirector/PDMR Shareholding
11th Oct 20224:33 pmRNSDirector/PDMR Shareholding
6th Oct 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.